These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 20477478

  • 1. Combining nuclear magnetic resonance spectroscopy and mass spectrometry in biomarker discovery.
    Gowda GA, Ijare OB, Shanaiah N, Bezabeh T.
    Biomark Med; 2009 Jun; 3(3):307-22. PubMed ID: 20477478
    [Abstract] [Full Text] [Related]

  • 2. Human bile as a rich source of biomarkers for hepatopancreatobiliary cancers.
    Gowda GA.
    Biomark Med; 2010 Apr; 4(2):299-314. PubMed ID: 20406071
    [Abstract] [Full Text] [Related]

  • 3. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
    Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, Cavill R, Nicholson JK, Keun HC.
    J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
    [Abstract] [Full Text] [Related]

  • 4. Analytical and statistical approaches to metabolomics research.
    Issaq HJ, Van QN, Waybright TJ, Muschik GM, Veenstra TD.
    J Sep Sci; 2009 Jul; 32(13):2183-99. PubMed ID: 19569098
    [Abstract] [Full Text] [Related]

  • 5. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review.
    Smolinska A, Blanchet L, Buydens LM, Wijmenga SS.
    Anal Chim Acta; 2012 Oct 31; 750():82-97. PubMed ID: 23062430
    [Abstract] [Full Text] [Related]

  • 6. Metabolomics: a new tool for the neonatologist.
    Atzori L, Antonucci R, Barberini L, Griffin JL, Fanos V.
    J Matern Fetal Neonatal Med; 2009 Oct 31; 22 Suppl 3():50-3. PubMed ID: 19701858
    [Abstract] [Full Text] [Related]

  • 7. Data mining of spectroscopic data for biomarker discovery.
    Norton SM, Huyn P, Hastings CA, Heller JC.
    Curr Opin Drug Discov Devel; 2001 May 31; 4(3):325-31. PubMed ID: 11560066
    [Abstract] [Full Text] [Related]

  • 8. Mass spectrometry-based immunoassays for the next phase of clinical applications.
    Nedelkov D.
    Expert Rev Proteomics; 2006 Dec 31; 3(6):631-40. PubMed ID: 17181477
    [Abstract] [Full Text] [Related]

  • 9. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH, Quo CF, Wang MD.
    Prog Brain Res; 2006 Dec 31; 158():83-108. PubMed ID: 17027692
    [Abstract] [Full Text] [Related]

  • 10. Targeted metabolomics for biomarker discovery.
    Griffiths WJ, Koal T, Wang Y, Kohl M, Enot DP, Deigner HP.
    Angew Chem Int Ed Engl; 2010 Jul 26; 49(32):5426-45. PubMed ID: 20629054
    [Abstract] [Full Text] [Related]

  • 11. The synergy of elemental and biomolecular mass spectrometry: new analytical strategies in life sciences.
    Becker JS, Jakubowski N.
    Chem Soc Rev; 2009 Jul 26; 38(7):1969-83. PubMed ID: 19551177
    [Abstract] [Full Text] [Related]

  • 12. Blind separation of analytes in nuclear magnetic resonance spectroscopy and mass spectrometry: sparseness-based robust multicomponent analysis.
    Kopriva I, Jerić I.
    Anal Chem; 2010 Mar 01; 82(5):1911-20. PubMed ID: 20131872
    [Abstract] [Full Text] [Related]

  • 13. Metabonomics: a useful tool for the future surgeon.
    Goldsmith P, Fenton H, Morris-Stiff G, Ahmad N, Fisher J, Prasad KR.
    J Surg Res; 2010 May 01; 160(1):122-32. PubMed ID: 19592031
    [Abstract] [Full Text] [Related]

  • 14. Gas chromatography/flame ionisation detection mass spectrometry for the detection of endogenous urine metabolites for metabonomic studies and its use as a complementary tool to nuclear magnetic resonance spectroscopy.
    Fancy SA, Beckonert O, Darbon G, Yabsley W, Walley R, Baker D, Perkins GL, Pullen FS, Rumpel K.
    Rapid Commun Mass Spectrom; 2006 May 01; 20(15):2271-80. PubMed ID: 16810707
    [Abstract] [Full Text] [Related]

  • 15. Combining desorption electrospray ionization mass spectrometry and nuclear magnetic resonance for differential metabolomics without sample preparation.
    Chen H, Pan Z, Talaty N, Raftery D, Cooks RG.
    Rapid Commun Mass Spectrom; 2006 May 01; 20(10):1577-84. PubMed ID: 16628593
    [Abstract] [Full Text] [Related]

  • 16. Quality control of herbal material and phytopharmaceuticals with MS and NMR based metabolic fingerprinting.
    van der Kooy F, Maltese F, Choi YH, Kim HK, Verpoorte R.
    Planta Med; 2009 Jun 01; 75(7):763-75. PubMed ID: 19288400
    [Abstract] [Full Text] [Related]

  • 17. A metabolomics perspective of human brain tumours.
    Griffin JL, Kauppinen RA.
    FEBS J; 2007 Mar 01; 274(5):1132-9. PubMed ID: 17298437
    [Abstract] [Full Text] [Related]

  • 18. Discovery of safety biomarkers for atorvastatin in rat urine using mass spectrometry based metabolomics combined with global and targeted approach.
    Kumar BS, Lee YJ, Yi HJ, Chung BC, Jung BH.
    Anal Chim Acta; 2010 Feb 19; 661(1):47-59. PubMed ID: 20113715
    [Abstract] [Full Text] [Related]

  • 19. Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
    Law WS, Huang PY, Ong ES, Ong CN, Li SF, Pasikanti KK, Chan EC.
    Rapid Commun Mass Spectrom; 2008 Aug 19; 22(16):2436-46. PubMed ID: 18634125
    [Abstract] [Full Text] [Related]

  • 20. Pattern recognition and biomarker validation using quantitative 1H-NMR-based metabolomics.
    Serkova NJ, Niemann CU.
    Expert Rev Mol Diagn; 2006 Sep 19; 6(5):717-31. PubMed ID: 17009906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.